IP Library Granted Patent US 10,883,099
Granted Patent B2
US 10,883,099 · App. 15/757,323 · Granted Jan 5, 2021

Small-molecule mediated size selection of nucleic acids

Inventors: Vince Moroney (Rancho Santa Fe, CA); Eddie Adams (San Diego, CA); Mark N. Brolaski (Encinitas, CA); Ingemar Pedron (San Diego, CA)
Assignee: QIAGEN Sciences, LLC
C12N15/101C12N15/1003C12N15/1006C12N15/1013C12N15/1017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,883,099
App. No.
15/757,323
Granted
Jan 5, 2021
Kind
B2
Abstract

Provided are methods and compositions for negatively and positively selecting for different size nucleic acid (e.g., DNA or RNA) fragments on borosilicate glass fiber membranes, silica and metal oxide surfaces such that only those fragments falling within a desired size range are obtained.

Claims (47)

1. A method of selectively isolating target nucleic acid molecules from a nucleic acid-containing sample, wherein the target nucleic acid molecules are within a particular molecular size range and non-target nucleic acid molecules are outside the molecular size range, comprising:

a) contacting a sample comprising nucleic acid molecules with a first matrix in the presence of a first small-molecule modulator, wherein

the first small-molecule modulator is present in a sufficient concentration that the target nucleic acid molecules selectively bind to the first matrix and non-target nucleic acid molecules do not bind to the first matrix,

increasing the concentration of the small-molecule modulator increases the molecular weight cut-off for nucleic acid molecules that bind to the matrix, and

the first small-molecule modulator

(1) is of formula (Ib) or a hydrate thereof:

(R 2 ) n M n+   (Ib)

wherein R 2 is a phosphate or a phosphonic acid;

M is a metal or N(R a ) 4 ;

each R a is independently H or alkyl; and

n is 1, 2, or 3; or

(2) is a carboxylate compound of formula (I) or a hydrate thereof

wherein R is selected from the group consisting of H, unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 1 -C 8 alkenyl, and substituted or unsubstituted C 1 -C 8 alkynyl;

M is a metal or N(R a ) 4 ;

each IV is independently H or alkyl; and

n is 1, 2, or 3.

2. The method of claim 1 , wherein greater than about 95% wt. % of the nucleic acid molecules bound to the first matrix are the target nucleic acid molecules.

3. The method of claim 1 , wherein greater than about 90% wt. % of the nucleic acid molecules bound to the first matrix are the target nucleic acid molecules.

4. The method of claim 1 , wherein greater than about 70% wt. % of the nucleic acid molecules bound to the first matrix are the target nucleic acid molecules.

5. The method of claim 1 , further comprising a step wherein the first matrix is washed to remove the unbound nucleic acid.

6. The method of claim 1 , further comprising a step wherein the bound nucleic acid molecules are eluted from the first matrix.

7. The method of claim 1 , wherein the first matrix comprises silica.

8. The method of claim 1 , wherein the first matrix comprises borosilicate glass.

9. The method of claim 1 , wherein the first matrix comprises silicon dioxide.

10. The method of claim 1 , wherein the first matrix comprises silicon dioxide-coated magnetic beads.

11. The method of claim 1 , wherein the first matrix comprises a metal oxide.

12. The method of claim 1 , wherein the first small-molecule modulator comprises a carboxylate moiety.

13. The method of claim 1 , wherein the first small-molecule modulator comprises a phosphate or phosphonate moiety.

14. The method of claim 1 , wherein the first small-molecule modulator comprises an ammonium or substituted ammonium moiety, acetate, or both an ammonium or substituted ammonium moiety and acetate.

15. The method of claim 1 , wherein the first small-molecule modulator is a carboxylate compound of formula (I), and wherein R is unsubstituted C 1 -C 8 alkyl.

16. The method of claim 15 , wherein R is CH 3 .

17. The method of claim 1 , wherein M n+ is Na + , Li + , K + , Ca 2+ , Mg 2+ , Al 3+ , or NH 4 + .

18. The method of claim 1 , wherein the first small-molecule modulator is ammonium acetate or sodium acetate.

19. The method of claim 1 , wherein the first small-molecule modulator is in a solution.

20. The method of claim 19 , wherein the solution further comprises guanidine hydrochloride, Tris-HCl, and isopropanol.

21. The method of claim 1 , wherein the nucleic acid comprises DNA.

22. The method of claim 1 , wherein the nucleic acid comprises RNA.

23. The method of claim 1 , wherein the first small-molecule modulator is present in a sufficient concentration that nucleic acid molecules of molecular size above the upper limit of the molecular size range selectively bind to the first matrix and nucleic acid molecules of molecular size below the upper limit of the target molecular size range do not bind to the first matrix; the method further comprises:

b) collecting all or a portion of the sample that is not bound to the first matrix;

c) contacting all or the portion of the sample that is not bound to the first matrix with a second matrix in the presence of a second small-molecule modulator,

wherein the second small-molecule modulator is present in a sufficient concentration that nucleic acid molecules of the target molecular size range selectively bind to the second matrix and nucleic acid molecules of molecular size below the lower limit of the molecular size range do not bind to the second matrix.

24. The method of claim 23 , wherein the first small-molecule modulator is a carboxylate compound.

25. The method of claim 23 , wherein the second small-molecule modulator is a carboxylate compound.

26. The method of claim 23 , wherein the concentration of the first small-molecule modulator is greater than the concentration of the second small-molecule modulator.

27. The method of claim 23 , wherein the nucleic acid molecules of molecular size above the upper limit of the target molecular size range are removed from the first matrix by washing or elution to produce the second matrix.

28. The method of claim 23 , wherein M n+ is Na + , Li + , K + , Ca 2+ , Al 3+ , or NH 4 + .

29. The method of claim 23 , wherein the first small-molecule modulator is the same as the second small-molecule modulator.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Apr 3, 2019
From: MO BIO LABORATORIES, INC.; QIAGEN SCIENCES, LLC
To: QIAGEN SCIENCES, LLC
Reel/Frame 048786/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2019
From: MORONEY, VINCE; ADAMS, EDDIE; BROLASKI, MARK N.; PEDRON, INGEMAR
To: MO BIO LABORATORIES, INC.
Reel/Frame 048789/0802 →
Continuity (2)
Provisional Application 62214862 · Sep 4, 2015
Related Publication 20180245064A1 · Aug 30, 2018